Synthesis and Structure–Activity Relationship Studies of Quinoxaline Derivatives as Aldose Reductase Inhibitors

Quinoxaline Aldehyde Reductase IC50
DOI: 10.1002/cmdc.201300324 Publication Date: 2013-10-04T09:52:10Z
ABSTRACT
ARIs for diabetes: A series of 2-(3-benzyl-2-oxoquinoxalin-1(2H)-yl)acetic acid derivatives were designed and synthesized as inhibitors aldose reductase (AR), a novel target the treatment diabetes complications. Most proved to be potent selective, with IC50 values in low nanomolar micromolar range.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (33)
CITATIONS (67)